STAT order: Should patients with chronic liver disease be prescribed statins to prevent fibrosis progression and hepatocellular carcinoma?
Hepatology
.
2016 Jul;64(1):13-5.
doi: 10.1002/hep.28537.
Epub 2016 Apr 15.
Authors
Juan G Abraldes
1
,
Kelly W Burak
2
Affiliations
1
Cirrhosis Care Clinic, Division of Gastroenterology (Liver Unit), University of Alberta, Edmonton, Alberta, Canada.
2
Calgary Liver Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada.
PMID:
26946464
DOI:
10.1002/hep.28537
No abstract available
Publication types
Editorial
Comment
MeSH terms
Carcinoma, Hepatocellular*
Disease Progression
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Liver Cirrhosis
Liver Neoplasms
Substances
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Grants and funding
U01 AA021908/AA/NIAAA NIH HHS/United States